檢索結果 - Vaibhav Sahai

Refine Results
  1. 1
    Statistical medium optimization and production of a hyperthermostable lipase from Burkholderia cepacia in a bioreactor

    Statistical medium optimization and production of a hyperthermostable lipase from Burkholderia cepacia in a bioreactor 由 Pooja Rathi, Vineet Kumar Goswami, Vaibhav Sahai, Rani Gupta

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma

    Epidermal Growth Factor Receptor Expression and Gene Copy Number in Conventional Hepatocellular Carcinoma 由 Anne F. Buckley, Lawrence J. Burgart, Vaibhav Sahai, Sanjay Kakar

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Opportunities and Challenges for Pancreatic Circulating Tumor Cells

    Opportunities and Challenges for Pancreatic Circulating Tumor Cells 由 Sunitha Nagrath, Rhonda M. Jack, Vaibhav Sahai, Diane M. Simeone

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression

    Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression 由 Surabhi Dangi‐Garimella, Vaibhav Sahai, Kazumi Ebine, Krishan Kumar, Hidayatullah G. Munshi

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma

    Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma 由 Sanjay Kakar, Guoren Deng, Thomas C. Smyrk, Lisa Cun, Vaibhav Sahai, Young S. Kim

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Targeting BET bromodomain proteins in solid tumors

    Targeting BET bromodomain proteins in solid tumors 由 Vaibhav Sahai, Amanda J. Redig, Katharine A. Collier, Frank Eckerdt, Hidayatullah G. Munshi

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study

    Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Revi... 由 Jonathan Strosberg, Al B. Benson, Lynn Huynh, Mei Sheng Duh, Jamie Goldman, Vaibhav Sahai, Alfred Rademaker, Matthew H. Kulke

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen

    BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen 由 Vaibhav Sahai, Krishan Kumar, Lawrence M. Knab, Christina R. Chow, Sania S. Raza, David J. Bentrem, Kazumi Ebine, Hidayatullah G. Munshi

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis

    Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis 由 Mario A. Shields, Kazumi Ebine, Vaibhav Sahai, Krishan Kumar, Kulsumjehan Siddiqui, Rosa F. Hwang, Paul J. Grippo, Hidayatullah G. Munshi

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01

    A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01 由 Vaibhav Sahai, Kent A. Griffith, Muhammad S. Beg, Walid L. Shaib, Devalingam Mahalingam, David B. Zhen, Dustin A. Deming, Mark M. Zalupski

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    P-286 Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-label, multicenter, single-arm, phase 1/2 study

    P-286 Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-l... 由 Vincent, Picozzi, Caio, Rocha Lima, Vaibhav, Sahai, Diane, Simeone, Allyson, Ocean, Philip, Philip, Wasif, Saif, Aparna, Kalyan, Michael, Ondovik, Jack, Shiansong Li, Victoria, Manax

    出版 2016
    獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  12. 12
    Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma

    Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma 由 Vaibhav Sahai, Paul J. Catalano, Mark M. Zalupski, Sam Joseph Lubner, Mark R. Menge, Halla Nimeiri, Hidayatullah G. Munshi, Al B. Benson, Peter J. O’Dwyer

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging

    Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging 由 Marina Baretti, Soumya Shekhar, Vaibhav Sahai, Daniel Shu, Kathryn L. Howe, Valerie Gunchick, Naziheh Assarzadegan, Emma Kartalia, Qingfeng Zhu, Elsa Hallab, Archit Sheth-Shah, Aya Kondo, Nilofer S. Azad, Mark Yarchoan

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

    Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma 由 Edward Kim, Vaibhav Sahai, Ethan V. Abel, Kent A. Griffith, Joel K. Greenson, Naoko Takebe, Gazala Khan, John Blau, Ronald A. Craig, Ulysses J. Balis, Mark M. Zalupski, Diane M. Simeone

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer

    ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer 由 Yiannis Drosos, David Escobar, Ming-Yi Chiang, Kathryn Roys, Virginia Valentine, Marc Valentine, Jerold E. Rehg, Vaibhav Sahai, Lesa Begley, Jianming Ye, Leena Paul, Peter J. McKinnon, Beatriz Sosa‐Pineda

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer

    Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer 由 Kyle C. Cuneo, Meredith A. Morgan, Vaibhav Sahai, Matthew J. Schipper, Leslie A. Parsels, Joshua D. Parsels, Theresa P. Devasia, Mahmoud Al-Hawaray, Clifford S. Cho, Hari Nathan, Jonathan Maybaum, Mark M. Zalupski, Theodore S. Lawrence

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

    Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer 由 Richard D. Kim, Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii‐Saab, Stacey Stein, Vaibhav Sahai, George P. Keogh, Edward Kim, Ari David Baron, Abby B. Siegel, Afsaneh Barzi, Katherine A. Guthrie, Milind Javle, Howard S. Höchster

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer

    GM-CSF Mediates Mesenchymal–Epithelial Cross-talk in Pancreatic Cancer 由 Meghna Waghray, Malica Yalamanchili, Michele Dziubinski, Mina Zeinali, Marguerite Erkkinen, Huibin Yang, Kara A. Schradle, Sumithra Urs, Marina Pasca di Magliano, Theodore H. Welling, Phillip L. Palmbos, Ethan V. Abel, Vaibhav Sahai, Sunitha Nagrath, Lidong Wang, Diane M. Simeone

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

    Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial 由 Michael J. Pishvaian, Edik M. Blais, Jonathan R. Brody, Emily E. Lyons, Patricia DeArbeloa, Andrew Hendifar, Sam Mikhail, Vincent Chung, Vaibhav Sahai, Davendra Sohal, Sara Bellakbira, Dzung Thach, Lola Rahib, Subha Madhavan, Lynn M. Matrisian, Emanuel F. Petricoin

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

    Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04) 由 Arathi Mohan, Kent A. Griffith, Fulei Wuchu, David B. Zhen, Chandan Kumar‐Sinha, Oxana Crysler, David Hsiehchen, Thomas Enzler, Dominique Dippman, Valerie Gunchick, Abhinav Achreja, Olamide Animasahun, Srinadh Choppara, Minal Nenwani, Arul M. Chinnaiyan, Deepak Nagrath, Mark M. Zalupski, Vaibhav Sahai

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: